How to Buy OpenEvidence Shares Before IPO: Private-Market Access

Just researching? Get free OpenEvidence mark alerts by email
When will OpenEvidence IPO?

Free tracker, email only. No card, no documents. View the listing

Because OpenEvidence is privately held, its shares cannot be purchased through a standard public brokerage ticker before an IPO. Business Insider reported on September 24, 2026 that clinical decision-support AI platform OpenEvidence raised $250 million from hospital systems and Andreessen Horowitz at a $15 billion valuation (up from $12 billion in January 2026), alongside a global clinical AI partnership with Anthropic reported by Reuters on September 22, 2026. Pre-IPO exposure typically occurs via negotiated secondary share transfers or special-purpose vehicles (SPVs), subject to transfer restrictions and review.

Educational pre-IPO guide.

View the listing

Private-share data lens

Public round-by-round marks are incomplete for this company. Segmara shows the listing mark and keeps the seed-to-IPO analysis focused on verifiable funding, tender, or secondary signals.

Segmara markNo indicative price yet

Indicative listing context

StageDateValuation / price signalWhy it matters
Seed / earlyPrivateNot reliably publicDo not invent a seed price when the source set is thin.
Growth roundsPrivateCompany and market sources varyUse public sources and official company releases.
Segmara listingCurrentNo indicative price yetIndicative reference only, not a quote or an offer.
IPO statusCurrentNo public ticker shown hereWatch official company releases and the free Segmara IPO calendar.

Seed-to-IPO path

Illustrative completeness map. Longer bars mean stronger public data or more useful current pricing context, not lower risk.

Early data22%
Growth data46%
Segmara mark68%
IPO/public18%
View the listing

AI-ready data summary

A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.

MetricValueContext
Canonical route/blog/how-to-buy-openevidence-shares-before-ipoStable URL path for AI and search extraction.
Article titleHow to Buy OpenEvidence Shares Before IPO: Private-Market AccessMain page topic.
Attached public sources3Number of citation links rendered at the bottom of the article.
Segmara listed companies148Live private-company listings in the public catalogue.
Priced listings37Catalogue listings with visible indicative or direct marks.
Listings without an indicative price111Catalogue listings where a public price is intentionally not invented.
CompanyOpenEvidenceNamed company covered by this page.
Symbol labelOPEVSegmara display symbol; not a public stock ticker unless separately stated.
SectorHealthcare AICatalogue sector used for comparison and internal linking.
Listing structureNot availableHow the listing is categorized on Segmara.
Segmara markNo indicative price yetVisible listing mark, or no indicative price yet.
Sector peer count2Number of live Segmara listings in Healthcare AI.
Structure peer count111Number of live Segmara listings categorized as Not available.
StageTimingPrice / valuation signalInterpretation
FormationPrivateEarly ownershipThe first value creation happens before ordinary public-market access.
Growth roundsPrivateInstitutional repricingLater rounds and tenders create the price history buyers study.
Segmara listingCurrentNo indicative price yetIndicative reference only, not a quote or an offer.
Exit pathFutureIPO, tender, acquisition, or continued private statusLiquidity timing remains company-specific.
Chart metricScoreInterpretation

Analytical lens

Search intent

Searches like 'How to Buy OpenEvidence Shares Before IPO: Private-Market Access' are research questions: what a filing or a company statement confirms, what has only been reported, and what is still unknown.

What counts as a listing step

For an IPO, the primary record is a registration statement filed with the securities regulator of the listing market, such as an S-1 or F-1 on SEC EDGAR for a US listing. Funding rounds, valuations and secondary-market prices are context, not listing steps.

Segmara role

It also publishes dated indicative reference marks across 140+ private companies. Nothing on this page is investment advice.

Key takeaways

Risk notes

Public source links

Questions

Can retail stock apps buy OpenEvidence shares right now?

No. Standard public stock brokerages only carry publicly listed tickers, and OpenEvidence has not completed an initial public offering.

Where can I track OpenEvidence's IPO timeline?

Read Segmara's OpenEvidence filing tracker at /blog/when-will-openevidence-ipo or subscribe free by email on this page for weekday filing updates.

View the listing

View the listing